AIDS Reviews Q3 Unclaimed
AIDS Reviews publishes papers reporting original scientific, clinical, epidemiologic and social research which contribute to the overall knowledge of the field of the acquired immunodeficiency syndrome and human retrovirology. Currently, the Journal publishes review articles (usually by invitation, but spontaneous submitted articles will also be considered). Manuscripts submitted to AIDS Reviews will be accepted on the understanding that the authors have not submitted the paper to another journa It has an SJR impact factor of 0,445.
Type: Journal
Type of Copyright:
Languages: English
Open Access Policy:
Type of publications:
Publication frecuency: -
- €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
0,445
SJR Impact factor62
H Index19
Total Docs (Last Year)86
Total Docs (3 years)630
Total Refs129
Total Cites (3 years)74
Citable Docs (3 years)1.57
Cites/Doc (2 years)33.16
Ref/DocOther journals with similar parameters
Swiss Medical Weekly Q3
Neurologia Q3
Canadian Journal of Experimental Psychology Q3
Journal of Physiology and Pharmacology Q3
Revista do Instituto de Medicina Tropical de Sao Paulo Q3
Compare this journals
Aims and Scope
Best articles by citations
Dolutegravir neuropsychiatric adverse events: specific drug effect or class effect
View moreBeyond Pegylated Interferon-Alpha: New Treatments for Hepatitis Delta
View moreQuantification of Hepatitis B Surface Antigen: Is there a Role in HIV-Hepatitis B Virus Coinfection?
View moreOvercoming Obstacles in Lipid-lowering Therapy in Patients with HIV - A Systematic Review of Current Evidence
View moreViral Inhibitory Activity of CD8+ T Cells in HIV Infection
View moreThe Use of Health Behavioral Theories in HIV/AIDS Research: A Bibliometric Analysis (Gap Research)
View moreState of the Art of Dual Therapy in 2015
View moreState of the Art of Dual Therapy in 2015
View moreManagement of Polypharmacy and Drug-Drug Interactions in HIV Patients: A 2-year Experience of a Multidisciplinary Outpatient Clinic
View moreReport from the International Conference on Viral Hepatitis (ICVH) -Chicago, October 2017
View moreIs Antiretroviral Two-Drug Regimen the New Standard for HIV Treatment in Naive Patients?
View moreHTLV-1 Associated Neurological Complex. What is Hidden below the Water?
View moreGenerics for the Treatment of Hepatitis C in Monoinfected And HIV-Coinfected Patients: Pros and Cons
View moreHIV and HCV in U.S. Prisons and Jails: The Correctional Facility as a Bellwether Over Time for the Community's Infections
View moreDisseminated Mycobacterium avium on HIV/AIDS: Historical and Current Literature Review
View moreRilpivirine: The Key for Long-term Success
View moreA Global Bibliometric Analysis of Services for Children Affected by HIV/AIDS: Implications for Impact Mitigation Programs (GAP RESEARCH)
View moreFactors Related to Hair Antiretroviral Concentration: A Systematic Review of Global Literature
View moreHIV/AIDS in Sierra Leone: Characterizing the Hidden Epidemic
View moreThe Role of HIV in the Progression through the Stages of the Human Papillomavirus to Cervical Cancer Pathway
View moreThe Safety and Efficacy of Marijuana in Persons Living with HIV
View moreMalignant Melanoma in People Living with HIV/AIDS: Can We Know More, Can We Do Better?
View moreToward the Cure of HIV-1 Infection: Lessons Learned and Yet to be Learned as New Strategies are Developed
View morePrevalence of Tuberculosis in HIV-positive Prisoners: A Systematic Review and Meta-analysis
View more
Comments